Coeptis Therapeutics, Inc. (COEP)
USD 0.18
(-16.07%)
USD 0.18
(-16.07%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2005 |
|---|---|---|---|---|---|---|
| Revenue | - | - | 75 Thousand | 30.76 Thousand | - | - |
| Cost of Revenue | 1 Million | 1 Million | 447.41 Thousand | 964.21 Thousand | - | - |
| Gross Profit | -1 Million | -1 Million | -372.41 Thousand | -933.45 Thousand | - | - |
| Operating Expenses | 20.48 Million | 34.19 Million | 14.12 Million | 5.77 Million | - | 308.3 Thousand |
| Selling, General and Administrative Expenses | 13.82 Million | 34.17 Million | 14.12 Million | 5.77 Million | - | 308.3 Thousand |
| Research and Development Expenses | 6.66 Million | 20.88 Thousand | - | 3543.00 | - | - |
| Other Expenses | - | 233.7 Thousand | 785.78 Thousand | -2.29 Million | - | - |
| Cost and Expenses | 21.49 Million | 34.19 Million | 14.12 Million | 6.74 Million | - | 308.3 Thousand |
| Operating Income | -21.49 Million | -34.19 Million | -14.04 Million | -6.86 Million | - | -308.3 Thousand |
| Interest Expense | -107.68 Thousand | 218.41 Thousand | 187.13 Thousand | 148.19 Thousand | - | - |
| Income Tax Expense | - | 3.39 Million | 972.91 Thousand | -2.14 Million | - | 36 Thousand |
| Earnings before Tax | -21.26 Million | -37.57 Million | -13.44 Million | -9.15 Million | -2234.00 | - |
| Net Income | -21.26 Million | -40.96 Million | -14.42 Million | -7 Million | -2234.00 | -344.3 Thousand |
| Earnings Per Share Basic | -0.83 | -2.87 | -0.71 | -0.34 | -0.00 | -184.81 |
| Earnings Per Share Diluted | -0.83 | -2.87 | -0.71 | -0.34 | -0.00 | -184.81 |
| Weighted Average Shares Outstanding | 25.68 Million | 14.29 Million | 20.44 Million | 20.44 Million | 10.78 Million | 1863.00 |
| Weighted Average Shares Outstanding (Diluted) | 25.68 Million | 14.29 Million | 20.44 Million | 20.44 Million | 10.78 Million | 1863.00 |
| Gross Margin | - | - | -4.97 | -30.35 | - | - |
| EBIT Margin | - | - | -170.84 | -282.33 | - | - |
| Profit Margin | - | - | -192.30 | -227.87 | - | - |
| EBITDA | -20.15 Million | -36.35 Million | -12.81 Million | -8.68 Million | 171.86 Thousand | -344.3 Thousand |
| Earnings Before Tax Margin | - | - | -187.28 | -223.06 | - | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | 1.5 Million | - | - | - |
| Cost of Revenue | 250.21 Thousand | 250.21 Thousand | 250.3 Thousand | 1 Million | 250.3 Thousand | 250.3 Thousand |
| Gross Profit | -250.21 Thousand | -250.21 Thousand | 1.25 Million | -1 Million | -250.3 Thousand | -250.3 Thousand |
| Operating Expenses | 2.57 Million | 2.67 Million | 3.11 Million | 20.48 Million | 7.81 Million | 3.59 Million |
| Selling, General and Administrative Expenses | 2.17 Million | 1.89 Million | 2.1 Million | - | 2.82 Million | 3.21 Million |
| Research and Development Expenses | 398.81 Thousand | 777.06 Thousand | 1.01 Million | - | 4.98 Million | 377.04 Thousand |
| Other Expenses | 8063.00 | 86.62 Thousand | -196.91 Thousand | - | -38.6 Thousand | - |
| Cost and Expenses | 2.82 Million | 2.92 Million | 3.36 Million | 21.49 Million | 7.81 Million | 3.59 Million |
| Operating Income | -2.82 Million | -2.92 Million | -3.36 Million | -21.49 Million | -7.83 Million | -3.63 Million |
| Interest Expense | 66.05 Thousand | 200.5 Thousand | 13.83 Thousand | -107.68 Thousand | 19.8 Thousand | 42.63 Thousand |
| Income Tax Expense | -1.00 | -1.00 | -1.41 Million | 4.00 | -18.8 Thousand | 42.63 Thousand |
| Earnings before Tax | -3.03 Million | -3 Million | -3.75 Million | -21.26 Million | -6.26 Million | -3.11 Million |
| Net Income | -3.03 Million | -3 Million | -3.75 Million | -21.26 Million | -6.26 Million | -3.11 Million |
| Earnings Per Share Basic | -0.08 | -0.08 | -0.11 | - | -0.23 | -0.14 |
| Earnings Per Share Diluted | -0.08 | -0.08 | -0.11 | - | -0.23 | -0.14 |
| Weighted Average Shares Outstanding | 37.56 Million | 35.54 Million | 35.33 Million | 25.68 Million | 26.65 Million | 21.8 Million |
| Weighted Average Shares Outstanding (Diluted) | 37.56 Million | 35.54 Million | 35.33 Million | 25.68 Million | 26.65 Million | 21.8 Million |
| Gross Margin | - | - | 0.83 | - | - | - |
| EBIT Margin | - | - | -2.07 | - | - | - |
| Profit Margin | - | - | -2.50 | - | - | - |
| EBITDA | -2.57 Million | -2.67 Million | -3.11 Million | - | -7.59 Million | -3.34 Million |
| Earnings Before Tax Margin | - | - | -2.24 | - | - | - |
BBZA
ALGEV
2871
306200
002232
1723